Published in Nat Rev Cancer on December 01, 2006
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res (2008) 1.83
Cigarette smoking and DNA methylation. Front Genet (2013) 1.48
Aberrant DNA Methylation: Implications in Racial Health Disparity. PLoS One (2016) 1.41
Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands. Proc Natl Acad Sci U S A (2009) 1.40
Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells. Carcinogenesis (2008) 1.37
Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish. BMC Genomics (2010) 1.37
Human cytochromes P450 in health and disease. Philos Trans R Soc Lond B Biol Sci (2013) 1.36
Cytochrome P450-derived eicosanoids: the neglected pathway in cancer. Cancer Metastasis Rev (2010) 1.36
Eicosanoid storm in infection and inflammation. Nat Rev Immunol (2015) 1.35
From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev (2008) 1.35
In utero tobacco exposure epigenetically modifies placental CYP1A1 expression. Metabolism (2010) 1.34
Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology. J Biol Chem (2008) 1.34
Dietary phytochemicals regulate whole-body CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut. J Clin Invest (2007) 1.33
A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol Appl Pharmacol (2009) 1.25
Nonadditive effects of PAHs on Early Vertebrate Development: mechanisms and implications for risk assessment. Toxicol Sci (2007) 1.19
EET signaling in cancer. Cancer Metastasis Rev (2011) 1.18
Phenotype of the Cyp1a1/1a2/1b1-/- triple-knockout mouse. Mol Pharmacol (2008) 1.15
Population-genetic nature of copy number variations in the human genome. Hum Mol Genet (2009) 1.12
Genome-wide B1 retrotransposon binds the transcription factors dioxin receptor and Slug and regulates gene expression in vivo. Proc Natl Acad Sci U S A (2008) 1.12
Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract. Free Radic Biol Med (2007) 1.08
Generation of 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-) mouse line. Biochem Biophys Res Commun (2007) 1.07
Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome. Cancer Epidemiol Biomarkers Prev (2008) 1.06
A large-scale survey of the novel 15q24 microdeletion syndrome in autism spectrum disorders identifies an atypical deletion that narrows the critical region. Mol Autism (2010) 1.03
Monocrotophos induced apoptosis in PC12 cells: role of xenobiotic metabolizing cytochrome P450s. PLoS One (2011) 1.00
Organ-specific roles of CYP1A1 during detoxication of dietary benzo[a]pyrene. Mol Pharmacol (2010) 0.99
An overview of genetic polymorphisms and pancreatic cancer risk in molecular epidemiologic studies. J Epidemiol (2010) 0.99
Analysis of human CYP1A1 and CYP1A2 genes and their shared bidirectional promoter in eight world populations. Hum Mutat (2010) 0.98
Knock-in mouse lines expressing either mitochondrial or microsomal CYP1A1: differing responses to dietary benzo[a]pyrene as proof of principle. Mol Pharmacol (2008) 0.98
The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer. PLoS One (2014) 0.98
Maternal smoking, GSTM1 and GSTT1 polymorphism and susceptibility to adverse pregnancy outcomes. Int J Environ Res Public Health (2009) 0.97
Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma. Mol Vis (2008) 0.97
Oral benzo[a]pyrene: understanding pharmacokinetics, detoxication, and consequences--Cyp1 knockout mouse lines as a paradigm. Mol Pharmacol (2013) 0.96
Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk. Carcinogenesis (2012) 0.96
Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation. Am J Physiol Gastrointest Liver Physiol (2012) 0.94
Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water. Crit Rev Toxicol (2015) 0.94
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver. Front Pharmacol (2010) 0.93
Efflux transporters: newly appreciated roles in protection against pollutants. Environ Sci Technol (2008) 0.93
Roles of nitric oxide in inflammatory downregulation of human cytochromes P450. Free Radic Biol Med (2007) 0.92
CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification. Cancer Res (2009) 0.90
Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies. Molecules (2012) 0.89
Regulation of endothelial cell functions by basement membrane- and arachidonic acid-derived products. Wiley Interdiscip Rev Syst Biol Med (2010) 0.88
Phase I to II cross-induction of xenobiotic metabolizing enzymes: a feedforward control mechanism for potential hormetic responses. Toxicol Appl Pharmacol (2009) 0.88
Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model. J Exp Clin Cancer Res (2009) 0.87
Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition. Chem Res Toxicol (2013) 0.87
Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity. Expert Opin Drug Metab Toxicol (2010) 0.87
CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis. World J Gastroenterol (2011) 0.87
The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice. Arch Toxicol (2015) 0.87
Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study. Asian J Androl (2009) 0.87
Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer. Carcinogenesis (2010) 0.86
Hepatic mRNA, microRNA, and miR-34a-target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation. Environ Mol Mutagen (2011) 0.86
Epigenome-Wide Association Studies (EWAS) in Cancer. Curr Genomics (2012) 0.86
Cytochrome P450 family 1 inhibitors and structure-activity relationships. Molecules (2013) 0.86
beta-Naphthoflavone protects mice from aristolochic acid-I-induced acute kidney injury in a CYP1A dependent mechanism. Acta Pharmacol Sin (2009) 0.86
A highly sensitive fluorogenic probe for cytochrome P450 activity in live cells. Bioorg Med Chem Lett (2008) 0.86
Zebrafish as model organisms for studying drug-induced liver injury. Br J Clin Pharmacol (2014) 0.85
Analysis of the secretomes of Paracoccidioides mycelia and yeast cells. PLoS One (2012) 0.85
A remarkable new target gene for the dioxin receptor: The Vav3 proto-oncogene links AhR to adhesion and migration. Cell Adh Migr (2010) 0.85
CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines. Toxicol Appl Pharmacol (2009) 0.85
Expression profile of CYP1A1 and CYP1B1 enzymes in colon and bladder tumors. PLoS One (2013) 0.85
MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis. PLoS One (2013) 0.85
Epigenetic silencing of CYP24 in the tumor microenvironment. J Steroid Biochem Mol Biol (2010) 0.84
Seasonal variations in the levels of PAH-DNA adducts in young adults living in Mexico City. Mutagenesis (2010) 0.84
DNA methylation and gene expression profiling of ewing sarcoma primary tumors reveal genes that are potential targets of epigenetic inactivation. Sarcoma (2012) 0.83
Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma. Sci Rep (2015) 0.83
New Trends in Aryl Hydrocarbon Receptor Biology. Front Cell Dev Biol (2016) 0.82
Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy. Drug Metab Dispos (2010) 0.82
Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls. Asian J Androl (2012) 0.82
Clinical and biochemical studies support smokeless tobacco's carcinogenic potential in the human oral cavity. Cancer Prev Res (Phila) (2013) 0.82
Regulatory crosstalk and interference between the xenobiotic and hypoxia sensing pathways at the AhR-ARNT-HIF1α signaling node. Chem Biol Interact (2014) 0.82
Gene-diet interactions in gastric cancer risk: a systematic review. World J Gastroenterol (2014) 0.82
Genetic polymorphisms in CYP1A1, CYP1B1 and COMT genes in Greenlandic Inuit and Europeans. Int J Circumpolar Health (2013) 0.81
Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice. Cancer Lett (2011) 0.81
Generation of a 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-)_Ahrd mouse line harboring the poor-affinity aryl hydrocarbon receptor. Biochem Biophys Res Commun (2008) 0.81
Cytochrome p450 1 genes in birds: evolutionary relationships and transcription profiles in chicken and Japanese quail embryos. PLoS One (2011) 0.81
Association between cytochrome P450 1A1 (CYP1A1) gene polymorphisms and the risk of renal cell carcinoma: a meta-analysis. Sci Rep (2015) 0.81
Effects of hypoxia exposure on hepatic cytochrome P450 1A (CYP1A) expression in Atlantic croaker: molecular mechanisms of CYP1A down-regulation. PLoS One (2012) 0.81
Natural allelic variations of xenobiotic-metabolizing enzymes affect sexual dimorphism in Oryzias latipes. Proc Biol Sci (2014) 0.81
Aryl hydrocarbon receptor expression is associated with a family history of upper gastrointestinal tract cancer in a high-risk population exposed to aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev (2009) 0.81
Cytochrome P450 3A1 mediates 2,2',4,4'-tetrabromodiphenyl ether-induced reduction of spermatogenesis in adult rats. PLoS One (2013) 0.81
Aryl hydrocarbon receptor-dependent upregulation of Cyp1b1 by TCDD and diesel exhaust particles in rat brain microvessels. Fluids Barriers CNS (2011) 0.80
Cytochrome P450 1B1 contributes to increased blood pressure and cardiovascular and renal dysfunction in spontaneously hypertensive rats. Cardiovasc Drugs Ther (2014) 0.80
Mitochondrial targeting of mouse NQO1 and CYP1B1 proteins. Biochem Biophys Res Commun (2013) 0.80
Epigenetic Regulation in Particulate Matter-Mediated Cardiopulmonary Toxicities: A Systems Biology Perspective. Curr Pharmacogenomics Person Med (2012) 0.80
Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women. Environ Health (2014) 0.80
Effect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver Microsomes. PLoS One (2015) 0.80
Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics. PLoS One (2014) 0.80
Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1. Free Radic Biol Med (2016) 0.80
Functional properties of the four Atlantic salmon (Salmo salar) aryl hydrocarbon receptor type 2 (AHR2) isoforms. Aquat Toxicol (2007) 0.79
Genotoxicity-related chemistry of human metabolites of benzo[ghi]perylene (B[ghi]P) investigated using electro-optical arrays and DNA/microsome biocolloid reactors with LC-MS/MS. Chem Res Toxicol (2013) 0.79
Health risk assessment for air pollutants: alterations in lung and cardiac gene expression in mice exposed to Milano winter fine particulate matter (PM2.5). PLoS One (2014) 0.79
Activation of aryl hydrocarbon receptor signaling by cotton balls used for environmental enrichment. J Am Assoc Lab Anim Sci (2009) 0.79
A common FMO3 polymorphism may amplify the effect of nicotine exposure in sudden infant death syndrome (SIDS). Int J Legal Med (2010) 0.78
Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma. World Rev Nutr Diet (2010) 0.78
Conservation and divergence of chemical defense system in the tunicate Oikopleura dioica revealed by genome wide response to two xenobiotics. BMC Genomics (2012) 0.78
Cytochrome-P450 enzymes and autoimmunity: expansion of the relationship and introduction of free radicals as the link. J Autoimmune Dis (2009) 0.78
Effects of schizonepetin on activity and mRNA expression of cytochrome p450 enzymes in rats. Int J Mol Sci (2012) 0.78
Identification of novel carcinogen-mediated mammary tumor susceptibility loci in the rat using the chromosome substitution technique. Genes Chromosomes Cancer (2010) 0.78
AhR activation underlies the CYP1A autoinduction by A-998679 in rats. Front Genet (2012) 0.78
Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: Application of the additive model for cancer. Genet Mol Biol (2011) 0.78
Prostaglandins and leukotrienes: advances in eicosanoid biology. Science (2001) 11.23
Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact (2006) 10.64
Polymorphic hydroxylation of Debrisoquine in man. Lancet (1977) 9.36
Nuclear receptors and lipid physiology: opening the X-files. Science (2001) 8.76
Pharmacogenomics: translating functional genomics into rational therapeutics. Science (1999) 8.25
Prooxidant states and tumor promotion. Science (1985) 6.26
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics (1996) 6.12
Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (1995) 6.03
Genetic engineering using homologous recombination. Annu Rev Genet (2002) 5.23
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics (2004) 5.12
Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest (2006) 4.92
Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res (1982) 4.78
Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem (2004) 4.10
Clinical importance of the cytochromes P450. Lancet (2002) 3.77
Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature (2003) 3.49
Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res (2005) 3.30
Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA (1996) 3.18
LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu Rev Physiol (2006) 3.11
CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet (2004) 3.03
Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol (2000) 3.01
At the crossroads of inflammation and cancer. Cell (2004) 2.96
The P450 gene superfamily: recommended nomenclature. DNA (1987) 2.95
Cytochrome P450 and the individuality of species. Arch Biochem Biophys (1999) 2.42
Cytochrome P450 pharmacogenetics and cancer. Oncogene (2006) 2.38
Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trends Pharmacol Sci (2004) 2.21
Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature (1984) 2.17
Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc (2004) 2.09
Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci U S A (1993) 2.08
N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene (2006) 2.03
The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev (2005) 2.03
Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Arch Biochem Biophys (2005) 1.91
A new cytochrome in liver microsomes. J Biol Chem (1962) 1.84
Modulation of paraoxonase (PON1) activity. Biochem Pharmacol (2005) 1.80
Hepatic uptake of chylomicron remnants. J Lipid Res (1997) 1.78
Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J Biol Chem (2000) 1.77
Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res (1988) 1.76
Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol Pharmacol (2004) 1.76
Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci U S A (1999) 1.73
Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab (2004) 1.71
Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Mol Pharmacol (2005) 1.71
Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am J Hum Genet (1997) 1.67
SITES OF INITIAL REMOVAL OF CHYLOMICRON TRIGLYCERIDE FATTY ACIDS FROM THE BLOOD. J Clin Invest (1962) 1.58
The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit Rev Toxicol (1989) 1.56
Prostaglandin E synthase: a novel drug target for inflammation and cancer. Curr Pharm Des (2006) 1.54
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics (2005) 1.53
The BARD1 Cys557Ser variant and breast cancer risk in Iceland. PLoS Med (2006) 1.53
Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am J Respir Cell Mol Biol (2006) 1.51
METABOLISM OF CONSTITUENT LIPIDS OF DOG CHYLOMICRONS. J Clin Invest (1963) 1.50
8-Oxoguanine DNA damage: at the crossroad of alternative repair pathways. Mutat Res (2003) 1.50
Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics (1995) 1.50
CYP2D6 genotyping and the association with lung cancer susceptibility. Pharmacogenetics (1994) 1.50
Regulation of hepatic transporters by xenobiotic receptors. Curr Drug Metab (2005) 1.49
The metabolism of certain drugs and food chemicals in man. Ann N Y Acad Sci (1971) 1.48
CAR, the continuously advancing receptor, in drug metabolism and disease. Curr Drug Metab (2005) 1.46
Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res (1982) 1.46
Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures. J Med Chem (2006) 1.42
Molecular genetics of primary congenital glaucoma. Eye (Lond) (2000) 1.42
Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype. Cancer Res (1989) 1.41
Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol (1996) 1.40
Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. Proc Natl Acad Sci U S A (1996) 1.35
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol (2005) 1.34
Enzyme-catalysed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and protein in vitro. Biochem J (1968) 1.33
Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology (2003) 1.30
Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol Endocrinol (1991) 1.30
Pharmacokinetic variability of anticancer agents. Nat Rev Cancer (2005) 1.29
Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur J Cancer (2005) 1.29
Pharmacogenomics and "individualized drug therapy": high expectations and disappointing achievements. Am J Pharmacogenomics (2003) 1.28
Pharmacogenetics of human cytosolic sulfotransferases. Oncogene (2006) 1.26
Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery. Biochem Biophys Res Commun (2000) 1.24
Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2. Chem Res Toxicol (2005) 1.22
Nuclear receptors and drug disposition gene regulation. J Pharm Sci (2005) 1.21
The toxicology of hydroquinone--relevance to occupational and environmental exposure. Crit Rev Toxicol (1999) 1.19
Glutathione S-transferase omega 1 and omega 2 pharmacogenomics. Drug Metab Dispos (2006) 1.17
Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus. Hum Mutat (2005) 1.15
Glutathione conjugate mediated toxicities. Toxicol Appl Pharmacol (1990) 1.14
Drug-metabolizing enzymes in ligand-modulated transcription. Biochem Pharmacol (1994) 1.12
Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc Natl Acad Sci U S A (2003) 1.12
Role of polymorphic human cytochrome P450 enzymes in estrone oxidation. Cancer Epidemiol Biomarkers Prev (2006) 1.11
Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 1.10
Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab Rev (1994) 1.10
Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead. Eur J Pharmacol (2004) 1.09
Liver deformation in Ahr-null mice: evidence for aberrant hepatic perfusion in early development. Mol Pharmacol (2006) 1.09
The aryl hydrocarbon receptor predisposes hepatocytes to Fas-mediated apoptosis. Mol Pharmacol (2004) 1.07
Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. Proc Natl Acad Sci U S A (2004) 1.06
Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children. Atherosclerosis (1987) 1.06
The mutagenic hazards of aquatic sediments: a review. Mutat Res (2004) 1.06
EPHX1 polymorphisms and the risk of lung cancer: a HuGE review. Epidemiology (2006) 1.05
Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2005) 1.03
The evolution of drug metabolism. Pharmacology (2000) 1.03
Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype. Pharmacogenet Genomics (2006) 1.02
Catalase enzyme mutations and their association with diseases. Mol Diagn (2004) 1.02
Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer. Anticancer Agents Med Chem (2006) 0.99
4-aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(-/-) and Cyp1a2(+/+) mice. J Natl Cancer Inst (2003) 0.98
Polymorphism of UDP-glucuronosyltransferase and drug metabolism. Curr Drug Metab (2005) 0.98
Effects of dietary constituents on the metabolism of chemical carcinogens. Cancer Res (1975) 0.97
Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer. Cancer Lett (1981) 0.96
Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis (2006) 0.95
Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: topical therapeutic strategies targeting COX-2 expression and activity. Anticancer Agents Med Chem (2006) 0.94
Role of TGFbeta in skin inflammation and carcinogenesis. Mol Carcinog (2006) 0.94
Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem (2004) 4.10
Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology (2007) 2.11
Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J Biol Chem (2002) 1.87
Dioxin increases reactive oxygen production in mouse liver mitochondria. Toxicol Appl Pharmacol (2002) 1.79
Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol Pharmacol (2004) 1.76
ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol Pharmacol (2006) 1.76
Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Mol Pharmacol (2005) 1.71
Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem (2006) 1.70
Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: similarities to the ZIP8 transporter. Mol Pharmacol (2008) 1.69
Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J Biol Chem (2005) 1.50
Decrease in 4-aminobiphenyl-induced methemoglobinemia in Cyp1a2(-/-) knockout mice. Toxicol Appl Pharmacol (2002) 1.44
Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J Neurosci (2010) 1.30
Butylhydroquinone protects cells genetically deficient in glutathione biosynthesis from arsenite-induced apoptosis without significantly changing their prooxidant status. Toxicol Sci (2005) 1.29
The role of metallothionein in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol (2005) 1.25
Cd2+ versus Zn2+ uptake by the ZIP8 HCO3--dependent symporter: kinetics, electrogenicity and trafficking. Biochem Biophys Res Commun (2007) 1.25
Mitochondrial reactive oxygen production is dependent on the aromatic hydrocarbon receptor. Free Radic Biol Med (2002) 1.24
Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria. Toxicol Appl Pharmacol (2004) 1.23
Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2. Chem Res Toxicol (2005) 1.22
Enhanced cadmium-induced testicular necrosis and renal proximal tubule damage caused by gene-dose increase in a Slc39a8-transgenic mouse line. Am J Physiol Cell Physiol (2006) 1.15
Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus. Hum Mutat (2005) 1.15
Glutathione redox state regulates mitochondrial reactive oxygen production. J Biol Chem (2005) 1.14
TCDD decreases ATP levels and increases reactive oxygen production through changes in mitochondrial F(0)F(1)-ATP synthase and ubiquinone. Toxicol Appl Pharmacol (2006) 1.13
Glutamate-cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress. Biochem Pharmacol (2002) 1.13
Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure. Hepatology (2007) 1.10
Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract. Free Radic Biol Med (2007) 1.08
Generation of 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-) mouse line. Biochem Biophys Res Commun (2007) 1.07
Uncoupling-mediated generation of reactive oxygen by halogenated aromatic hydrocarbons in mouse liver microsomes. Free Radic Biol Med (2004) 0.98
4-aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(-/-) and Cyp1a2(+/+) mice. J Natl Cancer Inst (2003) 0.98
Knock-in mouse lines expressing either mitochondrial or microsomal CYP1A1: differing responses to dietary benzo[a]pyrene as proof of principle. Mol Pharmacol (2008) 0.98
Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit. J Neurochem (2009) 0.96
Cyp1a2 protects against reactive oxygen production in mouse liver microsomes. Free Radic Biol Med (2004) 0.92
The metal-responsive transcription factor-1 contributes to HIF-1 activation during hypoxic stress. Biochem Biophys Res Commun (2005) 0.92
Intrinsic hepatic phenotype associated with the Cyp1a2 gene as shown by cDNA expression microarray analysis of the knockout mouse. EHP Toxicogenomics (2003) 0.91
Glutathione deficient C57BL/6J mice are not sensitized to ozone-induced lung injury. Biochem Biophys Res Commun (2010) 0.91
Interaction between the catalytic and modifier subunits of glutamate-cysteine ligase. Biochem Pharmacol (2007) 0.90
Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice. Pharmacogenet Genomics (2005) 0.89
Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis. J Hepatol (2010) 0.89
Comparison of mouse hepatic mitochondrial versus microsomal cytochromes P450 following TCDD treatment. Biochem Biophys Res Commun (2006) 0.88
For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequential. J Biol Chem (2006) 0.87
Generation of a Slc39a8 hypomorph mouse: markedly decreased ZIP8 Zn²⁺/(HCO₃⁻)₂ transporter expression. Biochem Biophys Res Commun (2011) 0.86
Early onset senescence occurs when fibroblasts lack the glutamate-cysteine ligase modifier subunit. Free Radic Biol Med (2009) 0.86
Pharmacological rescue of the 14CoS/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress. Free Radic Biol Med (2003) 0.84
Induction of oxidative stress responses by dioxin and other ligands of the aryl hydrocarbon receptor. Dose Response (2006) 0.84
Uroporphyrin accumulation in hepatoma cells expressing human or mouse CYP1A2: relation to the role of CYP1A2 in human porphyria cutanea tarda. Biochem Pharmacol (2003) 0.84
Antioxidant perturbations in the olfactory mucosa of alachlor-treated rats. Biochem Pharmacol (2003) 0.82
Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron. Hepatology (2002) 0.82
Naphthalene toxicity in mice and aryl hydrocarbon receptor-mediated CYPs. Biochem Biophys Res Commun (2006) 0.81
Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls-iron interaction: absence in the Cyp1a2(-/-) knockout mouse. Biochem Biophys Res Commun (2005) 0.80
Balancer-Cre transgenic mouse germ cells direct the incomplete resolution of a tri-loxP-targeted Cyp1a1 allele, producing a conditional knockout allele. Biochem Biophys Res Commun (2003) 0.80
Retrovirally expressed metal response element-binding transcription factor-1 normalizes metallothionein-1 gene expression and protects cells against zinc, but not cadmium, toxicity. Toxicol Appl Pharmacol (2002) 0.79
Genetic differences in lethality of newborn mice treated in utero with coplanar versus non-coplanar hexabromobiphenyl. Toxicol Sci (2005) 0.78
7H-dibenzo[c,g]carbazole metabolism by the mouse and human CYP1 family of enzymes. Carcinogenesis (2006) 0.77
Preservation of the negative image of tooth enamel with dental impression material enhances morphometric measurements of gingival overgrowth. Microsc Res Tech (2003) 0.75